Related Experiment Video
Updated: Aug 13, 2026
07:25
Ultrasonographic Evaluation of Salivary Glands for Sjogren's Syndrome: Diagnostic and Monitoring Insights
Published on: October 13, 2023
Bilateral diffuse tuberculosis of the parotid gland
V K Dhingra1, Sanjay Rajpal, U A Gupta
1Clinical Section, New Delhi Tuberculosis Centre, New Delhi, India. dhingra.vk@gmail.com
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
|January 31, 2006
Summary
Bilateral parotid gland tuberculosis is a rare condition. This case highlights successful diagnosis and treatment using Directly Observed Treatment Short Course (DOTS) for effective remission.
Area of Science:
- Otorhinolaryngology
- Infectious Diseases
- Oncology
Background:
- Tuberculosis (TB) typically affects the lungs, but extrapulmonary manifestations can occur.
- Parotid gland involvement is an uncommon presentation of tuberculosis.
- Bilateral and diffuse parotid gland tuberculosis is exceptionally rare.
Observation:
- A case study of a patient presenting with bilateral parotid gland swelling.
- Clinical examination revealed diffuse enlargement of both parotid glands.
- Fine needle aspiration cytology (FNAC) was performed for diagnosis.
Findings:
- FNAC confirmed the diagnosis of tuberculosis affecting both parotid glands.
- The patient received treatment with the Directly Observed Treatment Short Course (DOTS) category III regimen.
- The Revised National Tuberculosis Programme guided the treatment protocol.
Implications:
- This case underscores the importance of considering tuberculosis in the differential diagnosis of parotid gland masses.
- Successful management with DOTS highlights the efficacy of standardized TB treatment regimens for extrapulmonary TB.
- Further research into rare presentations of tuberculosis can improve diagnostic and therapeutic strategies.
Related Concept Videos
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...